申请人:Zhou Dahui
公开号:US20090069300A1
公开(公告)日:2009-03-12
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the histamine-3 receptor.
本发明提供了一种公式I的化合物及其用于治疗与
组胺-3受体相关或受其影响的中枢神经系统疾病的应用。